Literature DB >> 2155871

Genetic control of mouse cytomegalovirus-induced myocarditis.

C M Lawson1, H O'Donoghue, W N Bartholomaeus, W D Reed.   

Abstract

Mouse cytomegalovirus (MCMV) infection of mice induced myocarditis, characterized by a mononuclear cell infiltrate with associated necrosis of myofibres. Myocarditis was observed in parallel with viral inclusion-bearing cells in the heart during the acute phase of the infection. Myocarditis also persisted after the acute phase when viral antigens were no longer detectable by immunoperoxidase histochemistry and infectious virus could not be cultivated from various organs. The influence of host genetic factors on the development of cytomegalovirus-induced myocarditis was investigated using H-2 congenic and recombinant inbred mouse strains. Analysis of congenic variants with C57BL/10 and BALB/c backgrounds and the A/J strain revealed that genes linked to the H-2 complex influenced susceptibility to peak levels of MCMV-induced myocarditis seen 7 and 10 days post-infection. In addition, non-H-2 genes of the BALB/c background were important in determining the severity of myocarditis. Analysis of the strain distribution pattern of the CXB recombinant inbred series did not disclose the identity of the BALB/c non-H-2-linked allele conferring susceptibility to MCMV-induced myocarditis. The level of myocarditis seen in the F1 hybrid between the high-responder BALB/c and low-responder C57BL/6 strains suggested dominant inheritance. The amount of viral replication in the major target organs did not correlate with the severity of myocarditis. In conclusion, at least two genes, one mapping to the H-2 complex and another non-H-2-linked gene, influenced the development of myocarditis in MCMV-infected mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155871      PMCID: PMC1385714     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  CYTOMEGALIC INCLUSION DISEASE IN PATIENTS WITH ACUTE LEUKEMIA.

Authors:  G P BODEY; P T WERTLAKE; G DOUGLAS; R H LEVIN
Journal:  Ann Intern Med       Date:  1965-05       Impact factor: 25.391

2.  Inclusion disease or generalized salivary gland virus infection; report of five cases.

Authors:  E K AHVENAINEN
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1952-06

3.  Experimental herpes simplex virus carditis in mice.

Authors:  E I Grodums; A Zbitnew
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

Review 4.  Autoimmune myocarditis: a paradigm of post-infection autoimmune disease.

Authors:  N R Rose; A Herskowitz; D A Neumann; N Neu
Journal:  Immunol Today       Date:  1988-04

5.  Cytomegalovirus myocarditis.

Authors:  R S Wilson; T H Morris; J R Rees
Journal:  Br Heart J       Date:  1972-08

6.  Fatal cytomegalovirus infection in a previously healthy boy with myocarditis and consumption coagulopathy as presenting signs.

Authors:  E Tiula; P Leinikki
Journal:  Scand J Infect Dis       Date:  1972

7.  Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.

Authors:  N Neu; K W Beisel; M D Traystman; N R Rose; S W Craig
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

8.  Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection.

Authors:  D L Gang; L V Barrett; E J Wilson; R H Rubin; D N Medearis
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

9.  Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.

Authors:  W N Bartholomaeus; H O'Donoghue; D Foti; C M Lawson; G R Shellam; W D Reed
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

10.  Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.

Authors:  C M Lawson; J E Grundy; G R Shellam
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

View more
  9 in total

1.  Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.

Authors:  J C Lenzo; G R Shellam; C M Lawson
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  H-2 class I loci determine sensitivity to MCMV in macrophages and fibroblasts.

Authors:  P Price; A E Gibbons; G R Shellam
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Cytomegalovirus infection of adipose tissues induces steatitis in adult mice.

Authors:  P Price; K S Eddy; J M Papadimitriou; T A Robertson; G R Shellam
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

4.  Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice. Characterization of infiltrating cells.

Authors:  P Price; K S Eddy; J M Papadimitriou; D L Faulkner; G R Shellam
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

5.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

6.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

7.  Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.

Authors:  D Fairweather; C M Lawson; A J Chapman; C M Brown; T W Booth; J M Papadimitriou; G R Shellam
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

8.  Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.

Authors:  Sally Ann Huber; Brian Roberts; Mohamad Moussawi; Jonathan E Boyson
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

Review 9.  Don't Go Breaking My Heart: MCMV as a Model for HCMV-Associated Cardiovascular Diseases.

Authors:  Cassandra M Bonavita; Rhonda D Cardin
Journal:  Pathogens       Date:  2021-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.